BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34657628)

  • 1. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene.
    Chouk H; Ben Rejeb M; Boussofara L; Elmabrouk H; Ghariani N; Sriha B; Saad A; H'Mida D; Denguezli M
    Hum Genomics; 2021 Oct; 15(1):63. PubMed ID: 34657628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
    Morgan NV; Morris MR; Cangul H; Gleeson D; Straatman-Iwanowska A; Davies N; Keenan S; Pasha S; Rahman F; Gentle D; Vreeswijk MP; Devilee P; Knowles MA; Ceylaner S; Trembath RC; Dalence C; Kismet E; Köseoğlu V; Rossbach HC; Gissen P; Tannahill D; Maher ER
    PLoS Genet; 2010 Feb; 6(2):e1000833. PubMed ID: 20140240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive hearing loss associated with a unique cervical node due to a homozygous SLC29A3 mutation: a very mild phenotype.
    Jonard L; Couloigner V; Pierrot S; Louha M; Gherbi S; Denoyelle F; Marlin S
    Eur J Med Genet; 2012 Jan; 55(1):56-8. PubMed ID: 21888995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H syndrome: the first 79 patients.
    Molho-Pessach V; Ramot Y; Camille F; Doviner V; Babay S; Luis SJ; Broshtilova V; Zlotogorski A
    J Am Acad Dermatol; 2014 Jan; 70(1):80-8. PubMed ID: 24172204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
    de Jesus J; Imane Z; Senée V; Romero S; Guillausseau PJ; Balafrej A; Julier C
    Diabetes Metab; 2013 May; 39(3):281-5. PubMed ID: 23623699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
    Colmenero I; Molho-Pessach V; Torrelo A; Zlotogorski A; Requena L
    Am J Dermatopathol; 2012 May; 34(3):315-20. PubMed ID: 22356918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of H syndrome showing immunophenotye similarities to Rosai-Dorfman disease.
    Avitan-Hersh E; Mandel H; Indelman M; Bar-Joseph G; Zlotogorski A; Bergman R
    Am J Dermatopathol; 2011 Feb; 33(1):47-51. PubMed ID: 21178579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.
    Bolze A; Abhyankar A; Grant AV; Patel B; Yadav R; Byun M; Caillez D; Emile JF; Pastor-Anglada M; Abel L; Puel A; Govindarajan R; de Pontual L; Casanova JL
    PLoS One; 2012; 7(1):e29708. PubMed ID: 22238637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the SLC29A3 gene: a new cause of a monogenic, autoinflammatory condition.
    Melki I; Lambot K; Jonard L; Couloigner V; Quartier P; Neven B; Bader-Meunier B
    Pediatrics; 2013 Apr; 131(4):e1308-13. PubMed ID: 23530176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
    Al-Haggar M; Salem N; Wahba Y; Ahmad N; Jonard L; Abdel-Hady D; El-Hawary A; El-Sharkawy A; Eid AR; El-Hawary A
    Pediatr Diabetes; 2015 Jun; 16(4):305-16. PubMed ID: 24894595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homozygous frame-shift mutation in the SLC29A3 gene: a new case report and review of literature.
    Noavar S; Behroozi S; Tatarcheh T; Parvini F; Foroutan M; Fahimi H
    BMC Med Genet; 2019 Aug; 20(1):147. PubMed ID: 31464584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
    Elbarbary NS; Tjora E; Molnes J; Lie BA; Habib MA; Salem MA; Njølstad PR
    Pediatr Diabetes; 2013 Sep; 14(6):466-72. PubMed ID: 22989030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
    Farooq M; Moustafa RM; Fujimoto A; Fujikawa H; Abbas O; Kibbi AG; Kurban M; Shimomura Y
    Dermatology; 2012; 224(3):277-84. PubMed ID: 22653152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosai-Dorfman Disease and Exocrine Pancreatic Insufficiency in a Patient With a Germline SLC29A3 Mutation.
    Blatt J; Parekh P; Powell BC; Fedoriw Y; Reddy I; Montgomery ND
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e689-e691. PubMed ID: 32769566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease.
    Lara-Reyna S; Poulter JA; Vasconcelos EJR; Kacar M; McDermott MF; Tooze R; Doffinger R; Savic S
    J Clin Immunol; 2021 Feb; 41(2):441-457. PubMed ID: 33284430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygosity for a novel large deletion in SLC29A3 in a patient with H syndrome.
    Shankar SG; Rangarajan S; Priyadarshini A; Swaminathan A; Sundaram M
    Pediatr Dermatol; 2020 Mar; 37(2):333-336. PubMed ID: 31867772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.
    Rafiq NK; Hussain K; Brogan PA
    Pediatrics; 2017 Nov; 140(5):. PubMed ID: 29079714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the clinical spectrum of SLC29A3 gene defects.
    Spiegel R; Cliffe ST; Buckley MF; Crow YJ; Urquhart J; Horovitz Y; Tenenbaum-Rakover Y; Newman WG; Donnai D; Shalev SA
    Eur J Med Genet; 2010; 53(5):309-13. PubMed ID: 20619369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized pure cutaneous Rosai-Dorfman disease: a link between inflammation and cancer not associated with mitochondrial DNA and SLC29A3 gene mutation?
    Zheng M; Bi R; Li W; Landeck L; Chen JQ; Lao LM; Cai SQ; Yao YG; Man XY
    Discov Med; 2013 Nov; 16(89):193-200. PubMed ID: 24229736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric recurrent Rosai-Dorfman disease with germline heterozygous SLC29A3 and somatic MAP2K1 mutations.
    Suryaprakash S; George A; Langenburg S; Savaşan S
    Ann Hematol; 2020 Dec; 99(12):2965-2967. PubMed ID: 32944792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.